Skip to main content

Table 1 Baseline characteristics of the study population

From: Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study

Variable

n (%)

Gender

 Female

344 (85.2%)

 Male

60 (14.9%)

Age

 ≤ 20 year

43 (10.6%)

 20–40 year

179 (44.3%)

 > 40 year

182 (45.1%)

Underlying disease

 SLE

178 (44.1%)

 SS

72 (17.8%)

 SSc

39 (9.7%)

 RA

32 (7.9%)

 PM/DM

30 (7.4%)

 Primary vasculitis

11 (2.7%)

 MCTD

6 (1.5%)

 ALD

5 (1.2%)

 Others

31 (7.7%)

The source of MSCs

 UC

385 (95.3%)

 BM

17 (4.2%)

 UC/BM

2 (0.5%)

  1. SLE systemic lupus erythematosus, SS Sjögren’s syndrome, SSc systemic sclerosis, PM/DM polymyositis/dermatomyositis, RA rheumatoid arthritis, MCTD mixed connective tissue disease, ALD autoimmune liver disease